Use of serotonin receptor antagonists for the treatment of sleep apnea

Details for Australian Patent Application No. 2003301824 (hide)

Owner The Board of Trustees of the University of Illinois

Inventors Radulovacki, Miodrag; Carley, David W.

Agent Spruson & Ferguson

Pub. Number AU-B-2003301824

PCT Number PCT/US2003/0345

PCT Pub. Number WO2004/041272

Priority 10/285,277 31.10.02 US

Filing date 29 October 2003

Wipo publication date 7 June 2004

Acceptance publication date 4 September 2008

International Classifications

A61K 31/46 (2006.01) - 8-Azabicyclo [3.2.1] octane

A61K 31/48 (2006.01) - Ergoline derivatives, e.g. lysergic acid, ergotamine

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61K 31/551 (2006.01) - having two nitrogens as ring hetero atoms, e.g. clozapine, dilazep

A61K 31/5513 (2006.01)

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

Event Publications

24 June 2004 Complete Application Filed

  Priority application(s): 10/285,277 31.10.02 US

1 July 2004 Application Open to Public Inspection

  Published as AU-B-2003301824

4 September 2008 Application Accepted

  Published as AU-B-2003301824

8 January 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003301825-PANELS OF MOLECULAR TARGETS DIFFERENTIALLY EXPRESSED DURING CD8+ T CELL PRIMING, AND METHODS FOR THERAPY AND DIAGNOSIS UTILIZING THE SAME

2003301823-A protectant for UV-induced skin damage